Nano, Encarnacion T.

HRN: 28-60-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/04/2026
03/08/2026
IV
2.25g
Q8
RF Secondary To CAP HR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines